🚀 RECENT AI SUCCESS

Our AI successfully predicted the gap for $PUB.PA and executed a BUY strategy, securing a +9.52% net profit.

UPGRADE TO SEE LIVE SIGNALS

$EYPT

EyePoint Inc

United StatesUNITED STATES
FREE PREVIEW
📅 Next Earnings: Aug 05, 2026 ☀️ Open🌐 Website🏛️ NASDAQ📁 Health Technology🏭 Pharmaceuticals Major
AVG HISTORICAL GAP0.82%
MAX GAP RECORD13.71%
PREMIUM
AI ACCURACY RATE
92.4%
Unlock AI Insights 🔓

LAST 10 EARNINGS GAPS (%)

VOLATILITY & BIAS PROFILE

AVG VOLATILITY5.4%
Bullish Gaps
Bearish Gaps
Neutral

Intelligence Brief

EyePoint, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapeutics that treat eye disorders. It offers FDA-approved sustained-release treatments in ophthalmology under the DEXYCU, ILUVIEN, Verisome, Retisert, and Durasert brands. The company was founded in 1987 and is headquartered in Watertown, MA. Read full dossier

CURRENT AI SIGNAL
BULLISH STRONG
🔓 REVEAL SIGNAL